Maris A Cinelli

Title: Maris A Cinelli: Innovator in Neuronal Nitric Oxide Synthase Inhibition

Introduction

Maris A Cinelli is a prominent inventor based in Evanston, IL (US), known for her significant contributions to the field of neuroscience. With a total of 4 patents, she has made remarkable strides in developing compounds that target neuronal nitric oxide synthases (nNOSs), which play a crucial role in various neurological diseases.

Latest Patents

One of her latest patents involves selective neuronal nitric oxide synthase inhibitors. This patent discloses 7-phenyl-2-aminoquinoline compounds that effectively inhibit the biological activity of nNOSs. The patent also includes pharmaceutical compositions comprising these compounds and outlines methods for treating subjects in need. The disclosed compounds are particularly valuable for treating conditions associated with nNOS activity, including various neurological diseases and disorders. Another notable patent focuses on 2-aminoquinoline-based compounds that serve as potent and selective inhibitors of nNOS, applicable in both in vivo and in vitro settings.

Career Highlights

Maris A Cinelli is affiliated with Northwestern University, where she continues her research and innovation in the field of neuroscience. Her work has garnered attention for its potential impact on treating neurological disorders, showcasing her dedication to advancing medical science.

Collaborations

Throughout her career, Maris has collaborated with esteemed colleagues, including Richard B Silverman and Anthony V Pensa. These partnerships have further enriched her research and contributed to the development of her innovative patents.

Conclusion

Maris A Cinelli stands out as a leading inventor in the field of neuronal nitric oxide synthase inhibition. Her groundbreaking work and patents reflect her commitment to improving treatments for neurological diseases.